课题基金 / 基金详情

The use of patient derived gastric cancer organoids as a predictive tool to determine patient response to neoadjuvant chemotherapy

The use of patient derived gastric cancer organoids as a predictive tool to determine patient response to neoadjuvant chemotherapy
使用患者来源的胃癌类器官作为预测工具来确定患者对新辅助化疗的反应
批准号：
416974
负责人：
Skubleny Daniel T
金额：
$7.65万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-11-01 至 2022-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=416974&lang=en
关键词：
Biomarker Cancer Diagnosis And Detection Gastrointestinal Cancer Immunotherapy Molecular Biology Personalized Medicine Stomach Cancer Surgery

项目摘要

项目成果

Skubleny Daniel T的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Stomach cancer remains a deadly disease. In Canada, only 25% of patients diagnosed with stomach cancer survive five years after their diagnosis. Specific chemotherapy regimens established for stomach cancer have improved survival, however some cancers res
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biomarker expression and treatment response following neoadjuvant chemotherapy in western gastric cancer
  • 批准号：
    406335
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $1.27万
  • 财政年份：
    2018
  • 负责人：
    Skubleny Daniel T
  • 依托单位：
    University of Alberta